4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,400.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,435.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 813
  • Market Cap: £179.27m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,252,453 £17,534,342
Joseph Manuel Fernández 448,244 £6,275,416
David John Roth 316,000 £4,424,000
Maria Del Pilar de la Huerta 6,667 £93,338
Hansjörg Plaggemars 6,667 £93,338
Timothy Paul McCarthy 2,388 £33,432

Major Shareholders

Notifier** Holding Value*
DELPHI Unternehmensberatung AG 6,604,357 £92,460,998
Wilhelm K. T. Zours 6,604,357 £92,460,998
Deutsche Balaton AG 5,965,921 £83,522,894
4bb AG 3,665,242 £51,313,388
2invest AG 3,665,242 £51,313,388
Sparta AG 1,351,718 £18,924,052
Latonba AG 735,000 £10,290,000

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,400.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,435.00
52 Week Low 500.00
Volume 813
Shares Issued 12.81m
Market Cap £179.27m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.52% below the market average71.52% below the market average71.52% below the market average71.52% below the market average71.52% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average
Price Trend
99.77% above the market average99.77% above the market average99.77% above the market average99.77% above the market average99.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.95% below the market average34.95% below the market average34.95% below the market average34.95% below the market average34.95% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

4basebio Dividends

No dividends found

Trades for 03-Jun-2024

Time Volume / Share Price
12:26 281 @ 1,388.00p
12:25 281 @ 1,418.00p
11:21 7 @ 1,418.00p
08:02 211 @ 1,414.00p
08:00 33 @ 1,388.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page